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Abstract: Carpobrotus edulis, formerly known as Mesembryanthemum edule L, belongs to the Aizoaceae
family of plants. It is a facultative halophytic invasive medicinal and edible succulent plant that is
native to South Africa and is distributed worldwide. Hitherto, this plant appears to be mainly known
for its ornamental use in decorations, soil stabilization, and erosion control, and not for its many
potential medicinal and nutritional benefits, thus suggesting its underutilization. This review presents
cogent and comprehensive information on the distribution, ethnomedicinal use, phytochemistry,
pharmacology, toxicology, and nutritional value of Carpobrotus edulis and provides the rationale for
further pharmacognostic research that will validate its many folkloric medicinal and nutraceutical
claims, and promote its standardization into a commercially available product. The reported
traditional use of this plant for the treatment of sinusitis, diarrhoea, tuberculosis, infantile eczema,
fungal and bacterial infections, oral and vaginal thrush, high blood pressure, diabetes, wound
infections, spider and tick bites, sore throat as well as mouth infections are well documented.
Its therapeutic activities such as anti-proliferative, antioxidant, antifungal, antibacterial, antidiabetic,
anti-inflammatory, cytotoxicity, and nutritional value have also been reported to be attributable to the
array of phytoconstituents present in the plant. These have promoted renewed research interests into
this valuable medicinal plant with a view to repositioning and expanding its uses from the current
predominantly ornamental and environmental management role to include phytotherapeutical
applications through scientific validation studies that will improve its value for the drug discovery
process as well as its contribution to food security.
Keywords: Carpobrotus edulis; ethnomedicinal; photochemistry; pharmacology; therapeutic;
distribution; pharmaceutical
1. Introduction
Carpobrotus edulis (C. edulis) is a medicinal and edible succulent plant that belongs to the Aizoaceae
family, which is considered to be South Africa’s most diverse and abundant plant family that has
been the least studied for medicinal properties. C. edulis is a facultative halophyte that is common
in the Eastern and Western Cape regions of South Africa, but are widely found along other coastal
areas of Africa and other continents. C. edulis is known in English as Hottentot fig or highway ice
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plant or sour fig plant, while in Afrikaans, it is known by many names viz: “ghaukum”, “ghoenavy”,
“hottentotsvy”, “kaapsevy”, “perdevy”, “rankvy”, “suurvy”, or “vyerank”. In isiZulu, it is called
“ikhambi-lamabulawo” or “umgongozi” and its isiXhosa name is “igcukuma” [1].
C. edulis is a mat-forming plant with bright green foliage and leaves that could have red, orange,
or purple-coloured margins and surfaces [2] as shown in Figure 1 below. This plant reproduces both
sexually and asexually, producing large flowers and fleshy indehiscent fruits that contain arrays of
seeds. The plant grows by invading and colonizing the environment through its stolons, which spread
along the soil surface yielding new ramets at every node for proper propagation [3]. C. edulis can
be found on cliffs, coastal rocks, and dunes where it spreads widely, forming a creeping mat on
the surface, displacing several other coastal flora [4] and negatively affecting species diversity [5–7].
Some European countries have prohibited the release of plants belonging to the Carpobrotus species to
protected areas, mainly because of the invasiveness of this species [8].
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Figure 1. The flowering carpobrotus edulis plant and its taxonomy [2]. 
Although C. edulis is naturally distributed beyond the shores of Africa through mammals by 
way of ingesting the fruits and discarding its seeds, high adaptability and tolerance to environmental 
stress factors such as salinity, drought, and excess of light have helped to sustain its spread [9]. The 
family Aizoaceae and subfamily Rushhioideae contain about 1585 species in 112 genera that include 
C. edulis [10], thus, the proper identification of individual species has always been a challenge to 
botanical researchers, some of whom have only focused on the various parts of the plant that 
differentiate it from other closely-related species, especially Carpobrotus acinaciformis. The leaves of C. 
edulis are straight or sometimes curved and its receptacle is turbiniform, measuring between 20–40 
mm and elongating into the pedicel. The lobe of the calyx is unequal, the longest being 30–70 (80 mm) 
and shortest 10–35 mm, while the corolla has yellow petals that fade as the plant matures, while the 
ovary has about 7–11 loculi. These features are different in other Carpobrotus species [3,8,11]. 
The use of medicinal plants in drug development is well documented and research into these 
plants should take into consideration some criteria suggested by Baker et al. [12], which include the 
traditional use of the plant by the local population, the enormity of various ailments or diseases the 
plant is used for, the extent of geographical spread and availability of large quantities of the plant 
and finally, the natural sustainability of the plant over prolonged periods. Although C. edulis is one 
of the Carprobotus species that meet these criteria, its use for medicinal and nutritional purposes 
appears to be overshadowed by its other uses. There is a dearth of published information on C. edulis, 
hence, our aim in this review is to discuss its ethnopharmacology, phytochemistry, therapeutic use, 
and nutritional value and to provide new information on its potential role in plant-based drug 
discovery and development. 
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2. Research Methodology
A literature search was conducted with such keywords as Carpobrotus species, Carpobrotus
edulis, distribution, antioxidant, traditional use, medicinal uses, ethnomedicinal uses,
ethnopharmacology, phytochemistry, pharmacology, anti-proliferative, antifungal, antibacterial,
antidiabetic, anti-inflammatory, toxicity, food value in major databases including Science Direct, Google
Scholar, BioMed Central (BMC), Web of Science, Springer link, Scopus, and PubMed. Other important
information in this review was extracted from scientific articles, electronic books, conference papers,
and online theses.
2.1. Distribution and Survival of Carpobrotus edulis
C. edulis is native to the Eastern Cape, Western Cape, and Northern Cape provinces of South
Africa where it grows predominantly on the slopes of inland and coastal areas of low elevations [8].
Some authors have reported that C. edulis is abundant along the coast of Portugal [13,14] and is well
distributed and grown in Australia [15], New Zealand [16], Northern Africa [17], North America [8],
South America [18], Western Asia [19], and Europe [20]. This plant was introduced to Europe, Australia,
New Zealand, Southern Europe, and the USA as an ornamental plant in the 19th century [3,21] and is
planted along highways, beach parking lots, military and private yards, among other locations for the
purposes of soil stabilization and aesthetics [22]. Some of the factors that have ensured the survival
of C. edulis include the plant’s ability to adjust to the available levels of nutrients [23], survival in
saline environments [24], adaptability to variable pH levels [25] as well as the ability to reproduce both
vegetatively and sexually [26].
2.2. Taxonomic Classification of Carpobrotus edulis
Domain: Eukaryota; Kingdom: Plantae; Phylum: Spermatophyta; Subphylum: Angiospermae;
Class: Dicotyledonae; Order: Caryophyllales; Family: Aizoaceae; Genus: Carpobrotus; Species:
Carpobrotus edulis.
2.3. Traditional Use of Carpobrotus edulis
Thring and Weitz [27] documented and reported on some medicinal plants including C. edulis
that are of enormous importance for the treatment of many disease conditions. The juice and sap from
C. edulis leaves are traditionally used to treat throat and mouth infections [28], dysentery [29] and
digestive problems [28,29], tuberculosis [28], and skin conditions such as burns and wounds as well
as for the management of common infections in HIV/AIDS [1]. These authors have also reported the
use of C. edulis for the treatment of toothache, earache, oral thrush, virginal thrush, blood pressure,
and diabetes mellitus [1]. C. edulis has also been reported to play an important role as a traditional
food additive to improve the nutrient composition of food, as its edible fleshy shoot when soaked in
water and well-prepared has been used as a food preservative [30]. A summary of the traditional use
of this plant is shown in the Table 1 below.
Table 1. Ethnomedicinal uses of Carpobrotus edulis.
Part of Plant Used or
Administered Traditional Use Reference
Leaves—Leaf juice or leaf pulp
Used to treat inflammation, dysentery, digestive
troubles, tuberculosis, toothache, earache. The juice
is used as an antiseptic for wounds and burns and
vaginal thrush.
[29,31,32]
Leaves—The juice from the
powdered leaf Treatment of oral thrush. [27,29,33–35]
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Table 1. Cont.
Part of Plant Used or
Administered Traditional Use Reference
Leaves—Leaf juice or leaf pulp
Treatment of throat infections, burn stomach




Food and antimicrobial Food agent. The dried fruits
are eaten directly or used to make jams, preserves
and act as a flavor.
[38]
2.4. Phytochemistry of Carpobrotus edulis
Phytochemicals are secondary metabolites responsible for the many activities often associated
with the use of medicinal plants for the treatment, amelioration, and management of various ailments
including life-threatening diseases. The qualitative phytochemical screening of C. edulis for its content of
twelve important phytochemicals namely saponins, chlorides, sulfates, coumarins, flavonoids, alkaloids,
anthraquinones, iridoids, cyanogenic glycosides, cardiac glycosides, carbohydrates/glycosides,
unsaturated sterols/triterpenoids and tannins has been reported by Eman [39]. All the identified
phytochemicals except iridoids were found to be present in varying amounts in the different plant
parts: stem, leaves, and flowers of C. edulis [39]. Furthermore, the preparation of the various extracts of
C. edulis leaves with water, ethanol, acetone, and hexane solvents revealed differences in the content of
phenols, flavonoids, flavonols, proanthocyanidins, tannins, saponins, and alkaloids, as shown in the
table below [1].
The evaluation of the amount of phytochemicals revealed that the leaf extract of C. edulis had
557 ± 0.23 mg TE/g (Trolox equivalent) of phenolic content, 1.19 ± 0.04 mg QE/g (Quercetin equivalent)
of the flavonoid content, and 489 mg/g of tannin content, which were highest for the acetone, hexane,
and ethanol solvents, respectively [1] as seen in Table 2. In contrast, a similar study carried out on the
peel and flesh of C. edulis fruit indicated that the peel of the fruit of C. edulis had 272.83 ± 5.59 mg TE/g
of phenolic content, 1.58 ± 0.10 mg TE/g of flavonoid content, and 20.3 ± 0.98 mg/g of tannin content,
with the highest values from the ethanol solvent only in comparison with other solvents [39]. Overall,
no single solvent can completely extract the various phytochemicals because of the huge difference in
the chemical properties of these phytochemicals. In addition, the amount of phytochemicals in the
plant varies with the different part of the plant and season of harvest. Chokoe et al. [40] reported that
the C. edulis leaves harvested during autumn had higher amounts of these phytochemicals regardless
of the solvent of extraction when compared with other parts of the plant.
Table 2. Evaluation of the quantities of phytochemicals in the leaf extract of Carpobrotus edulis. Data were
obtained in triplicate and presented as mean ± standard deviation [1].
Phytochemicals Aqueous Ethanol Acetone Hexane
Phenols mg TE/g 517 ± 0.40 330.8 ± 0.04 557 ± 0.23 64.14 ± 0.15
Flavonoids mg QE/g 0.29 ± 0.01 0.28 ± 0.01 0.65 ± 0.04 1.19 ± 0.04
Flavonols mg QE/g 0.05 ± 0.001 0.05 ± 0.001 0.023 ± 0.05 0.19 ± 0.03
Proanthocyanidins mg CE/g 896 ± 0.05 115.28 ± 0.007 753.87 ± 0.02 134.91 ± 0.01
Tannins (mg/g) 461 ± 0.07 489 ± 0.38 384 ± 0.14 64 ± 0.14
Saponins (mg/g) 34 ± 0.21 45 ± 0.26 11 ± 0.071 2 ± 0.035
Alkaloids (mg/g) 45 ± 0.06 38 ± 0.02 31 ± 0.021 3 ± 0.015
In one study on C. edulis, van der Watt and Pretorius [41] reported that flavonoids are the major
component of the leaves of this plant that include ferulic acid, catechol, tannins, rutin, neohesperidin,
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and hyperosides. The structures of some of the phytochemicals identified in C. edulis are shown in
Figure 2 below. These active principles such as flavonoids have been reported to mitigate infections
caused by bacteria [42–44] and have also been reported to have cardioprotective, antiviral, and anticancer
properties. The first evidence of the presence of potent phenolics in C. edulis was obtained from the use
of LC/ESI-MS/MS techniques to fractionate the extract, yielding procyanidins and propelargonidins as
the major active polyphenolics present [45]. It was demonstrated that β-carotene bleaching inhibition,
in vitro DPPH, and ABTS free radical scavenging activities of C. edulis confer biological actions such as
immunomodulatory, antioxidant, and neuroprotective potential in drug development.Sci. Pharm. 2020, 88, x FOR PEER REVIEW 5 of 15 
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and inhibition of P-glycoprotein that causes drug resistance in cancer. Furthermore, essential oils from
the leaves of C. edulis have been identified to contain some active components or phytochemicals [46],
which include monoterpenes, oxygenated monoterpenes, diterpenes, oxygenated diterpenes, and fatty
acids. The essential oils consist of different components that function in diverse ways that are beneficial
to human health. The antioxidant, antimicrobial, and immune-modulating activities of C. edulis could
be linked to these active components of essential oils, especially the monoterpenes, sesquiterpenes,
diterpenes, and fatty acid esters [46].
The Table 3 below shows some of the identified components of the essential oils following
hydro-distillation and analysis with gas chromatography mass spectrometry (GC-MS) techniques of
the acetone, hexane, and ethanolic extracts of the leaves of C. edulis. A total of twenty-eight compounds
that account for 99.99% of the total essential oils were identified in the leaves of C. edulis [46].
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Benzoic acid, 2,5-bis (trimethylsiloxy-,trimethylsilyl ester) C16H30O4Si3
Hexadecanoic acid, ethyl ester C18H36O2
Hexadecanoic acid, 1-methyl ethyl ester C19H38O2
Many of the secondary metabolites in medicinal plants including C. edulis are known to have a
wide range of beneficial properties that has attracted so much attention to the use of medicinal plants
as candidates for the development of drugs [47], possibly because medicinal plants are adjudged to
have potent pharmacological actions, are affordable, relatively safe, and readily available.
Sci. Pharm. 2020, 88, 39 7 of 16
2.5. Toxicity Studies on Carpobrotus edulis
Most medicinal plants have age-long use for the treatment of various diseases and their
safety can only be guaranteed through in vitro and in vivo screening experiments that monitor
mutagenicity, carcinogenicity, or embryotoxicity [48,49]. In one study, some medicinal plants
including Carpobrotus mellei, Carpobrotus quadrifidus, and Carpobrotus edulis were subjected to the
brine shrimp lethality test to determine cytotoxicity [50]. Findings revealed that the aqueous extract of
Carpobrotus mellei and the methanolic extract of Carpobrotus quadrifidus were more toxic in the brine
shrimp lethality test than C. edulis, with a death rate of 47.43% and 48.06% for test durations of 24 h
and 48 h, respectively [35]. The results from this study were also corroborated by another study in
which the aqueous and methanolic extracts of C. edulis were found to be safe or non-toxic in the brine
shrimp lethality bioassay [32].
In a study to investigate the potential of the aqueous–acetone extract of C. edulis in a tissue
regeneration study using the flatworm Dugesia sicula as a model, the administration of the phenols
from the C. edulis extract in the medium of Dugesia sicula at non-toxic concentrations revealed
morphological alterations from the macroscopic analysis done, indicating possible toxicological effects
of the polyphenols in the extract [51].
3. Biological Activity of Carpobrotus edulis
The in vitro biological activities of C. edulis showed that the plant has antioxidant, immunoactive,
antimicrobial, neuroprotective, and anticholinesterase properties [52–55]. Furthermore, this plant has
also been reported to have anticancer [54], anti-bacterial [41], and antifungal properties [46].
3.1. Antibacterial Properties
Multi-drug resistance (MDR) is a major challenge in the treatment of most infections including
those caused by bacteria. Medicinal plants have long been used for MDR and the methanolic extract of
C. edulis is known to be inactive against two bacteria, namely, methicillin-resistant-Staphylococcus aureus
and the multidrug-resistant Mycobacterium tuberculosis [55]. The treatment of monocyte-derived human
macrophages with the methanolic extract of C. edulis led to the inhibition of the growth of both bacteria,
possibly via phagocytosis. This may be due to the ability of the monocyte-derived macrophages to
concentrate the extract more than the highest concentration that is obtainable in the in vitro studies [55].
The inhibition of growth provides the scientific evidence and rationale for the use of this plant in
traditional medicine for the treatment of infections [28] and also suggests that the plant could serve as
an effective antimicrobial agent against MDR intracellular infections [55].
Furthermore, Martins et al. [45] reported on six compounds isolated from an extract of C. edulis,
namely uvaol, β-amyrin, oleanolic acid, catechin, epicatechin, and monogalactosyldiacylglycerol and
their activity against different strains of bacteria. These compounds were tested for their activity
against the efflux pump system of Gram-negative and Gram-positive bacteria and found to have
varying effects. Oleanolic acid showed the highest activity in most of the bacterial strains tested while
the greatest modulation or inhibition of efflux activity of MDR Gram-positive strains was attributed
to uvaol, a tripertene, which was the most potent isolated compound. Meddeb and colleagues also
reported that the aqueous–acetone extract of C. edulis contains different amounts of phenolics such as
gallic acid, chlorogenic acid, catechin, 1,3-dicaffeoylquinic acid, caffeic acid and ferulic acid, which were
adjudged to be effective against Gram-positive B. cereus and S. aureus as well as S. epidermidis. However,
this extract did not show remarkable antimicrobial effects against Gram-negative E. coli, P. aeruginosa,
and S. typhimurium [51].
Loaiza et al. [39] evaluated the fruit peel and flesh extracts of C. edulis for antibacterial
activity against both Gram-positive and Gram-negative bacteria namely Escherichia coli ATCC 25922,
Pseudomonas aeruginosa ATTC 27853, Klebsiella pneumoniae ATCC 70603, Staphylococcus aureus ATCC
43300 (MRSA), Salmonella enteritidis ATTC 13076, Sarcina lutea ATCC 9341, Proteus mirabilis ATCC 25933,
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Bacillus cereus ATCC 11778, Staphylococcus epidermidis NRRL B-4268 and Listeria monocytogene NRRL
B33314 using the slightly modified broth microdilution method with gentamicin used as a standard
drug. The peel extracts were generally more active than the flesh extracts and mostly more effective
against Gram-positive than Gram-negative bacteria. However, no activity was observed for both
these extracts against P. aeruginosa, K. pneumoniae, P. mirabilis and C. albicans. The ethanol peel extract
showed the highest activity against S. epidermidis with a minimum inhibitory concentration (MIC) of
0.78 mg/mL, much lower than for other extracts [39].
3.2. Antifungal Properties
Omoruyi et al. [46] reported the antifungal activities of the hexane, acetone, ethanol, and aqueous
leaf extracts of C. edulis on five pathogenic fungal strains: Candida albican, Candida krusei, Candida rugosa,
Candida glabrata, and Cryptococcus neoformans. The results showed MIC values ranging between
0.02–0.031 mg/mL. The hexane extract was found to be the most potent against all five fungal strains
with MICs ranging between 0.02–1.25 mg/mL, while the aqueous and ethanolic extracts had no
noticeable antifungal activity. In addition, the acetone extract showed substantial activity against
Candida krusei only, with a MIC of 0.04 mg/mL [46]. The activity of the essential oil extracted
from the leaves of C. edulis was also tested against five pathogenic fungal strains and found to be
similar to the high potency observed for the hexane extract, which is in agreement with the work of
Steenkamp et al. [56].
Furthermore, the study carried out on the anti-fungal activity of the peel and flesh extracts of
the fruit of C. eduli against Candida parapsilopsis, and Candida albican ATCC 2655 showed that both
the aqueous and ethanol extracts of the peel of C. edulis fruit only inhibited the growth of Candida
parapsilopsis alone, having the same MIC of 6.25 mg/mL while no activity was detected for the flesh of
C. eduli fruit extracts against the two fungal strains tested [39].
3.3. Antioxidant Properties
The antioxidant characteristics and phenolic compounds extracted from the leaves, stem, and roots
of C. edulis were evaluated in vitro using different assays such as total antioxidant capacity, DPPH
scavenging activity, iron reducing power, and β-carotene bleaching test (BCBT) were conducted by
Falleh et al. [43]. The different parts of the plant were found to have higher antioxidant activity when
compared with butylated hydroxytoluene BHT, the positive control, in the order: stem > leaf > roots.
Reversed-phase High Performance Liquid Chromatography (RP-HPLC) analysis was also used to
determine the phenolic composition in the extracts and the highest amount of polyphenolic compounds
was 86.5 mg GAE g−1 DW in the stem extract and 68.7 mg GAE g−1 DW in the leaf extracts of C. edulis,
respectively. Catechin and procyanidins B2 were more abundant in the stem, while quercitrin and
avicularin were more abundant in the leaves of C. edulis as revealed by HPLC analysis [43].
Omoruyi et al. [1] reported the antioxidant activity of the aqueous, ethanol, acetone,
and hexane extracts of C. edulis using the 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2′-azino-bis
(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) diammonium salt, hydrogen peroxide (H2O2),
nitric oxide (NO), and the ferric reducing power (FRAP) assays. The findings indicated variations
in the percentages of the phytoconstituents based on the different solvents used for the extraction.
The acetone extract was reported to contain more phenolics at 55.7 ± 0.404%; the aqueous extract
had more proanthocyanidins (86.9 ± 0.005%) while the ethanol extract had 4.5 ± 0.057% alkaloids,
48.9 ± 0.28% tannins, and 4.5 ± 0.262% saponins, respectively [1]. Flavonoids and flavonols were
greater in the hexane extract when compared with other extracts, while the aqueous and ethanol
extracts demonstrated a strong inhibition against the DPPH, ABTS, and NO scavenging radicals.
The findings from this work indicate that both the aqueous and ethanol extracts of C. edulis leaves
were the best for assessing antioxidant capacity [1].
Falleh et al. [57] investigated the phenolic contents of the varying leaf, stem, and root
aqueous–methanolic fractions of C. edulis. The phenol-rich fractions of 20%, 60%, and 40% in
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the leaf, stem, and root extracts respectively ranged from 671 to 989 mg GAE g−1 DR. The FRAP
value was found to be 40% in the leaf and 40% in the stem extracts, representing 86 and 96 µg/mL−1,
respectively, and the highest total antioxidant effect was seen in the root (40%), representing 395 mg
GAE g−1 DR. Thus, various parts of C. edulis are potential sources of natural antioxidants [57].
3.4. Neuroprotective Properties
The first evidence of the neuroprotective effects of C. edulis was reported by Custódio et al. [52],
who showed that the methanolic extracts of C. edulis could inhibit both acetylcholinesterase and
butyrylcholinesterase enzymes (dual role), thus providing a basis for the potential use of the
plant for the management and treatment of different neurodegenerative disorders of the brain [58].
Cholinesterase inhibitors (ChEIs) are important mechanism-mediated molecules that alleviate cognitive
dysfunction [58].
A study by Mulaudzi and co-workers on the inhibitory capacity of various extracts of C. edulis
against the acetylcholinesterase enzyme (AChE) using a colorimetric method of analysis showed
that the 50% methanolic, 70% acetone, and aqueous extract of C. edulis had half-maximal inhibitory
concentration (IC50) of 28.8 ± 3.07 mg/mL, 34.0 ± 2.88 mg/mL, and 20.0 ± 0.08 mg/mL, respectively,
at 1 mg/mL of the extract compared with the standard drug Galanthamine, which had an IC50 value
of 82.8 ± 0.29 µM against AChE [59]. These extracts showed lower anticholinesterase activity in
comparison with a similar Carpobrotus species, Carpobrotus dimidiatus [59]. The neuroprotective action
of C. edulis via the inhibition of AChE could be accentuated by an increase in cholinergic function
induced by the nutritionally important polyunsaturated fatty acids (PUFAs) present in C. edulis [52],
which is known to inhibit AChE hydrolysis or enhance AChE release to alleviate disease symptoms [60].
Another neuroprotection study by Enogieru et al. [61] in our research group showed that pre-treatment
with the aqueous extract of C. edulis prevented apoptosis and oxidative stress in a cellular model
of Parkinson’s disease (PD) and provides the rationale for further investigation of the effects of this
plant on other pathophysiological pathways of this disease. Another study by Zarrock et al. [62]
7βhydroxycholesterol (7β-OHC), was found to induce cell death and oxidative stress in cultured
murine oligodendrocytes (158N) and these effects were reversed by the ethanol–water extract of
C. edulis, which demonstrated the neuroprotective potential of this extract in age-related diseases
associated with oxidative stress and lipid peroxidation.
3.5. Antidiabetic Properties
Diabetes and its complications remain one of the major non-communicable health conditions
that are prevalent in both developed and developing countries of the world. Different mechanisms
are targeted in research that is aimed at the development of effective anti-diabetic drugs. The use of
medicinal plants in the development of drugs for the treatment of diabetes is preferred over synthetic
drugs, which are known to have many deleterious side effects.
Oxidative stress and pro-inflammatory advanced glycation end products (AGEs) remain some
of the mechanisms that aggravate the complications of diabetes mellitus. Hafsa et al. [36] reported
the antiglycation activity of C. edulis extracts for the first time and found that there was significant
inhibition of the fluorescent AGEs formed by the ethanol–water extract of C. edulis. The antiglycation
property or the inhibitory mechanisms of (AGEs) are important for the prevention and amelioration of
induced AGE diabetic complications [63]. This antiglycation property or inhibitory effect on protein
glycation is an important attribute of the C. edulis ethanol–water extract [36] and could support other
evidence to justify the traditional use of C. edulis for the treatment of diabetes mellitus. Furthermore,
one of the most important mechanisms for the development of drugs for the treatment of diabetes
mellitus is the inhibition of α-amylase and α-glucosidase activity. The development of inhibitors
for these carbohydrate-metabolizing enzymes has helped to regulate postprandial hyperglycemia in
circulation, which is an important strategy in the treatment of diabetes mellitus [64,65]. In type 2
diabetes mellitus, abnormalities of glucose homeostasis are linked to postprandial hyperglycemia,
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which that is observed early enough in the pathophysiology of diabetes mellitus. Overall, α-amylase
and α-glucosidase inhibitors could regulate abysmal glucose levels after carbohydrate catabolism.
Medicinal plants have become attractive for the treatment of postprandial hyperglycemia because
they are adjudged not to cause hypoglycemia, have good safety profiles, do not induce insulin secretion
while regulating postprandial hyperglycemia, and have less side effects compared to available synthetic
drugs [64,66,67].
The potential anti-diabetic activity of C. edulis leaf extracts via the inhibition of α-glucosidase by its
aqueous, methanol (50%), and acetone (70%) extracts was evaluated by Mulaudzi and colleagues [59].
The aqueous extract showed an IC50 value of 5 µg/mL compared with the standard α-glucosidase
inhibitor, acarbose, which has an IC50 value of 429 µg/mL, a reflection of the high significance of
α-glucosidase inhibition; this further substantiates the use of water to prepare C. edulis extracts
as done traditionally in the treatment of diabetes mellitus. Overall, the C. edulis leaf extracts had
strong inhibitory action against α-glucosidase enzymes in the in vitro assay [59]. In another study,
the aqueous, ethanol, and acetone extracts from the fruits of C. edulis were shown to display low
inhibition activity to α-amylase and α-glucosidase enzymes, ranging from 0.13 ± 0.01 to 0.24 ± 0.01
mmol/ACAE/g and 0.33 ± 0.02 to 0.47 ± 0.01 mmol/ACAE/g, respectively [39]. This result was in
contrast to a previous study that reported a higher enzymatic inhibitory activity at an IC50 value of
5 µg/mL [59]. This probably provides scientific evidence or support for the use of this plant for the
traditional treatment and management of diabetes mellitus.
3.6. Anti-Inflammatory Properties
Inflammation is a protective response by the body to ensure the removal of detrimental stimuli,
as well as a healing process for repairing damaged tissue caused by such factors as microbial
infection, cellular injury, and myocardial infarction [68]. Many diseases such as arthritis, polymyalgia
rheumatica, heart conditions, asthma, cancer, and inflammatory bowel are linked to inflammatory
processes [69,70] while in conditions such as diabetes mellitus, inflammation is adjudged a common
risk factor of their pathogenesis [59,71]. Drugs that alleviate or ameliorate inflammation and its
associated painful episodes often work through hindering the enzymes needed by the body to produce
pro-inflammatory eicosanoids [72]. Eicosanoids such as prostanoids, leukotrienes, and thromboxanes
are pro-inflammatory mediators that are produced when cyclooxygenase (COX), lipoxygenase (LOX),
and P 450 epoxygenase metabolize arachidonic acid in the metabolic pathway [73], and these
molecules are implicated in many pathological conditions that are related to the inflammatory process.
Targeting or inhibition of these molecules is important in biological processes to ameliorate inflammation.
Some medicinal plants are known to have an effective anti-inflammatory activity or potential as a result
of which much attention is now being given to the isolation of novel anti-inflammatory compounds
with minimal or no side-effects from medicinal plants.
Mulaudzi et al. [59] reported that the aqueous, methanol (50%), and acetone (70%) extracts
of C. edulis subjected to the 15-lipoxygenase (LOX) enzyme inhibition model had IC50 values of
59.8 ± 5.50 µg/mL, 120.2 ± 17.42 µg/mL, and 22.3 ± 4.11 µg/mL, respectively. The IC50 value not greater
than 100 µg/mL obtained from the 70% acetone and water extracts of C. edulis indicated the strong
potential of these extracts to inhibit the LOX enzyme, which is one of the key enzymes implicated in
inflammation. The C. edulis extracts had a significant LOX-17 inhibitory activity when compared with
extracts of C. dimidiatus [59], whereas the C. dimidiatus leaf extracts exhibited higher cyclooxygenase-2
(COX-2) than COX-1 enzyme inhibition than C. edulis in another study by Fawole et al [69].
3.7. Antiproliferative Properties
Many studies have validated the use of different medicinal plants as antiproliferative or anti-cancer
agents [74–79]. There are pieces of scientific evidence to show that C. edulis extracts have anti-cancer
properties that promote the inhibition of abnormal cell growth in different cancer cell lines caused
by oncogenic factors. Ordway et al. [56] showed that the methanolic leaf extract of C. edulis at
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non-toxic concentrations could inhibit the verapamil sensitive pump of the L5178 mouse T-cell
lymphoma cell line. Evidence on the anti-proliferative property of C. edulis leaf extract showed that
P-glycoprotein, known for its drug resistance potential, was inhibited in the mouse lymphoma cell
lines [47]. Seven compounds were identified from the methanolic extract of C. edulis subjected to
fractions of chloroform and ethyl acetate using 1D, 2D NMR, and MS and these include such triterpenes
as β-amyrin, uvaol, oleanolic acid, monogalactosyldiacylglycerol, catechin, and epicatechin as well as
procyanidin B5. Overall, the antiproliferative activity and the reversal of multidrug resistance in MDR
mouse lymphoma cell lines was the most significant with the compound uvoal, compared with other
compounds tested [45].
Hafsa et al. [36] reported the cytotoxic effects and hence the anti-proliferative activities of the
aqueous and ethanol–water (same ratio) extracts of C. edulis on human colon cancer cell lines (HCT-116).
This study showed that the ethanol–water extract significantly decreased cell viability after 24-h
incubation compared to the aqueous extract [36], and this anti-proliferative effect could be attributed to
the constituents, especially the seven major phenolics: sinapic acid, ferulic acid, luteolin 7-O-glucoside,
hyperside, isoquercitin, ellagic acid, and isorhamnetin 3-O-rutinoside. A recent in vitro preliminary
cytotoxicity study on the effects of C. edulis on U251 and U87 malignant glioblastoma cell lines showed
that the extract elicits an anti-proliferative property and also inhibited colony formation in U251
cells [80].
4. Dietary Uses of Carpobrotus edulis
Many medicinal plants are edible and contain quality nutrients, thus presenting reasonable
potential to be developed into a new food product or prepared into such nutrient-rich condiments
as food additives, spices, and flavors. Other forms of preparation could include tonics, nuts, wine,
jelly, and vegetables, to mention a few. Van Wykj reported that 16 indigenous plants from South
Africa including C. edulis gave rise to 119 commercialized African products of which food products or
additives are prominent. The fruits of C. edulis were rated very high for the production of such food
products as jam, chutney, or sauce and other dried processed products [81].
In one study, the leaves of C. edulis were evaluated to ascertain adequacy and suitability for human
composition in terms of nutrients and safety. The parameters of proximate chemical analysis evaluated
showed that antioxidants were higher than other halophytes, an indication that C. edulis has a great
potential as a nutritional supplement to tackle oxidative-stress linked disease conditions [53]. Similarly,
edible wild fruits of five Carpobrotus species including C. edulis were assessed for their nutritional
significance through proximate chemical analysis [82]. Findings showed considerably high moisture
levels of 77.6% to 90.3%, carbohydrate levels of 58.8% to 70.3%, energy levels of 1240 to 1370 kJ 100 g−1,
and protein levels were considered adequate at 8.1% to 26.0%. On the other hand, the lipid levels were
considered low at 0.9% to 2.4%, while the elemental concentrations were in the decreasing trends of Ca
> Mg > Fe > Mn > Zn~Cu > Cr > Se~Ni~Co [82]. Overall, the findings from the study showed that the
Carpobrotus species evaluated could positively contribute to human nutritional needs in the form of a
dietary supplement because of the rich array of essential nutrients in these plants compared to most
cultivated fruits like oranges, apples, and grapes. This could potentially contribute positively to the
improvement of global food security since these plants have been reported to be widely distributed in
different parts of the world.
5. Conclusions
An extensive literature search was done for this review to reveal important ethnopharmacological,
phytochemical, and biological properties of Carpobrotus edulis as well as its nutritional value. It is clear
from the literature search that this plant has been an important source of traditional medicines for
decades, especially for the management of tuberculosis and other respiratory infections, toothaches
and earaches, facial eczema, wounds and burns, hypertension, and diabetes mellitus, among others.
Some of the ethnomedicinal uses of this plant have been scientifically validated and pharmacological
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activities such as antimicrobial, anti-proliferative, antioxidant, neuroprotective, anti-inflammatory,
and antidiabetic activities have also been studied as discussed in this review. The non-therapeutic
uses of C. edulis including its nutritional use were also highlighted. It is hoped that this review will
elicit renewed research interests in this valuable medicinal plant with the overall aim of repositioning
and expanding its uses from its predominantly ornamental and environmental management role
to evidence-based phytotherapeutic uses through scientific studies aimed at validating its folkloric
medicinal and therapeutic efficacy for drug discovery and development purposes. Hitherto, only limited
in vitro scientific studies have been reported, hence more scientific validation studies are necessary
in the form of toxicological and pharmacological profiling of Carpobrotus edulis in more in vitro and
animal models, as a prelude for human investigations through clinical trials.
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